You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunogenicity

Showing 8976 - 8992 of 8,992
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in St Louis, Rochester (rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine)

Completed
  • HIV Infections
  • rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine
  • St Louis, Missouri
  • +1 more
Jun 23, 2005

Prevention of Anthrax Infection Trial in United States (rPA102 Vaccine)

Completed
  • Prevention of Anthrax Infection
  • rPA102 Vaccine
  • Atlanta, Georgia
  • +3 more
Jun 23, 2005

HIV Trial in San Francisco (HIV-1 Peptide Vaccine, Microparticulate Monovalent, rgp120/HIV-1MN Monovalent Octameric V3 Peptide

Completed
  • HIV Infections
  • HIV-1 Peptide Vaccine, Microparticulate Monovalent
  • rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine
  • San Francisco, California
    Univ of California at San Francisco Gen Hosp
Jun 23, 2005

HIV Trial in Baltimore, Rochester (HIV-1 Peptide Vaccine, Microparticulate Monovalent)

Completed
  • HIV Infections
  • HIV-1 Peptide Vaccine, Microparticulate Monovalent
  • Baltimore, Maryland
  • +1 more
Jun 23, 2005

HIV Trial in Baltimore, Nashville, Seattle (P3C541b Lipopeptide)

Completed
  • HIV Infections
  • P3C541b Lipopeptide
  • Baltimore, Maryland
  • +2 more
Jun 23, 2005

HIV Trial in Birmingham, Rochester, Seattle (HIV-1 Peptide Vaccine, Microparticulate Monovalent, HIV-1 Peptide Immunogen,

Completed
  • HIV Infections
  • HIV-1 Peptide Vaccine, Microparticulate Monovalent
  • HIV-1 Peptide Immunogen, Multivalent
  • Birmingham, Alabama
  • +2 more
Jun 23, 2005

Level of Immunity Against Poliovirus Infection Trial (Inactivated Polio Vaccine given at an accelerated schedule)

Completed
  • Level of Immunity Against Poliovirus Infection
  • Inactivated Polio Vaccine given at an accelerated schedule
  • (no location specified)
Nov 29, 2005

HIV Trial in St Louis, Rochester, Nashville (rgp120/HIV-1IIIB, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • rgp120/HIV-1IIIB
  • rgp120/HIV-1MN
  • St Louis, Missouri
  • +2 more
Jun 23, 2005

Impact of HIV on Measles and Measles Immunisation

Completed
  • HIV Infection
  • +2 more
  • standard-titer measles vaccine
  • Lusaka, Zambia
    Chawama Clinic
Oct 28, 2005

Anthrax Trial in United States (rPA102)

Completed
  • Anthrax
  • rPA102
  • Torrance, California
  • +11 more
Jan 10, 2006

HIV Trial in United States (MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, MN rgp120/HIV-1 and A244 rgp120/HIV-1, Aluminum hydroxide)

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
  • +2 more
  • Denver, Colorado
  • +3 more
Jun 23, 2005

Cytokines in Guillain Barré Syndrome: Correlation With Clinical

Unknown status
  • Guillain Barré Syndrome
    • Taipei, Taiwan
      Department of Anatomy and Cell Biology, National Taiwan Universi
    Nov 29, 2005

    HIV, HIV Seronegativity Trial in Omaha (HIV p24/MF59 Vaccine)

    Completed
    • HIV Infections
    • HIV Seronegativity
    • HIV p24/MF59 Vaccine
    • Omaha, Nebraska
      Creighton Univ Med Ctr / Ped Infect Disease Div
    Jun 23, 2005

    HIV, Cytopenias Trial in Los Angeles, Boston (Sargramostim)

    Completed
    • HIV Infections
    • Cytopenias
    • Los Angeles, California
    • +1 more
    Jun 23, 2005

    Multiple Sclerosis Trial (mAb M-T412)

    Completed
    • Multiple Sclerosis
    • monoclonal antibody M-T412
    • (no location specified)
    Jun 23, 2005

    Adenocarcinoma Trial in Bronx (ING-1(heMAb))

    Completed
    • Adenocarcinoma
    • Bronx, New York
      Jack D. Weiler Hospital of the Albert Einstein College of Medici
    Jun 23, 2005

    Pertussis Trial (diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis, diphtheria-tetanus vaccine)

    Completed
    • Pertussis
    • diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis
    • diphtheria-tetanus vaccine
    • (no location specified)
    Jun 23, 2005